Trends and Predictors of Poor Outcomes in Patients With Right Heart Failure: Insights From the National Readmission Database.


Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 18 01 2023
accepted: 23 01 2023
medline: 1 5 2023
pubmed: 2 2 2023
entrez: 1 2 2023
Statut: ppublish

Résumé

Right heart failure (RHF) is a complex clinical syndrome that confers high risk of morbidity and mortality. We sought to study RHF using large national database. The study is a retrospective analysis of the National Readmission Database (NRD) of years 2017-2019. Admissions with a primary diagnosis of RHF were included. Study outcomes were temporal trends of RHF diagnosis and predictors of in-hospital mortality and 30-day readmission. Subgroup analysis according to co-presence of reduced or preserved left ventricular ejection fraction (LVEF). Multivariate logistic regression was utilized to detect predictors of poor outcome and difference between subgroups. A total of 127,503 admissions were identified from the database of which 4,717 primary RHF admissions were included in our cohort. There was a trend of increasing RHF diagnosis from 2017 4th Quarter to 2019 4th Quarter. Age, liver disease and reduced LVEF were amongst predictors of in-hospital mortality while iron deficiency anemia and a Charlson Comorbidity Score ≥ 3 were predictors of 30-day readmission. The study of real-world data contributes to a better understanding of RHF outcomes. Further studies are needed to investigate the association between RHF and different types of heart failure and its implications on clinical practice.

Identifiants

pubmed: 36724819
pii: S0146-2806(23)00042-7
doi: 10.1016/j.cpcardiol.2023.101625
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101625

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Ahmed Maraey (A)

Department of Internal Medicine, University of North Dakota SW Campus, Bismarck, ND. Electronic address: maraeyahmed@gmail.com.

Alexander G Hajduczok (AG)

Department of Cardiology, Thomas Jefferson University, Philadelphia, PA.

Mustafa Ozbay (M)

Department of Internal Medicine, New York College of Medicine, Metropolitan Hospital, New York, NY.

Wael Abdelmottaleb (W)

Department of Internal Medicine, New York College of Medicine, Metropolitan Hospital, New York, NY.

Mahmoud Salem (M)

Department of Cardiology, UPMC Heart and Vascular Institute, Harrisburg, PA; Center for Advanced Heart Failure, Baylor University Medical Center, Dallas, TX.

Mahmoud Khalil (M)

Department of Internal Medicine, Lincoln Medical Center, Bronx, NY.

Ayman Saeyeldin (A)

Center for Advanced Heart Failure, Baylor University Medical Center, Dallas, TX.

Hadeer Elsharnoby (H)

Department of Internal Medicine, Carle Foundation Hospital, Urbana, IL.

Amit Alam (A)

Center for Advanced Heart Failure, Baylor University Medical Center, Dallas, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH